300119 瑞普生物
按盤價 
18.880 +1.350 (+7.701%)
18.880 +1.350 (+7.701%) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 8.732 | 6.656 | 10.324 | 8.401 | 12.724 |
| 總資產報酬率 ROA (%) | 5.128 | 4.017 | 6.919 | 5.878 | 8.609 |
| 投入資產回報率 ROIC (%) | 6.324 | 5.030 | 8.256 | 6.800 | 10.137 | 邊際利潤分析 |
| 銷售毛利率 (%) | 41.277 | 41.376 | 43.642 | 48.441 | 51.804 |
| 營業利潤率 (%) | 14.112 | 12.156 | 21.031 | 19.990 | 24.879 |
| 息稅前利潤/營業總收入 (%) | 14.870 | 12.883 | 21.843 | 20.686 | 25.238 |
| 淨利潤/營業總收入 (%) | 12.784 | 10.744 | 19.010 | 17.933 | 21.602 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 80.386 | 103.124 | 66.825 | 85.140 | 72.810 |
| 價值變動淨收益/利潤總額(%) | 23.381 | -0.425 | 13.377 | 13.396 | 27.115 |
| 營業外收支淨額/利潤總額(%) | -1.890 | -1.325 | 0.253 | -0.683 | -2.372 | 償債能力分析 |
| 流動比率 (X) | 1.786 | 1.621 | 2.224 | 2.362 | 2.724 |
| 速動比率 (X) | 1.520 | 1.399 | 1.907 | 2.081 | 2.404 |
| 資產負債率 (%) | 32.279 | 37.144 | 28.857 | 26.287 | 24.024 |
| 帶息債務/全部投入資本 (%) | 23.835 | 24.919 | 18.017 | 17.485 | 15.519 |
| 股東權益/帶息債務 (%) | 305.683 | 288.756 | 441.069 | 460.543 | 524.461 |
| 股東權益/負債合計 (%) | 190.309 | 151.073 | 225.844 | 262.994 | 294.971 |
| 利息保障倍數 (X) | 14.581 | 14.537 | 28.796 | 24.855 | 26.968 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 107.169 | 118.848 | 114.927 | 113.600 | 91.101 |
| 存貨周轉天數 (天) | 90.348 | 99.652 | 101.843 | 121.862 | 134.805 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 07/04/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
